Erectile Dysfunction (ED) Clinical Trials

Find Erectile Dysfunction (ED) Clinical Trials Near You

Multimodal Perioperative Optimisation for Patients Undergoing Robot-Assisted Radical Prostatectomy: A Randomised Controlled Trial Targeting Postoperative Erectile Dysfunction (ROBOPREP Trial)

Status: Recruiting
Location: See all (3) locations...
Intervention Type: Behavioral, Drug
Study Type: Interventional
Study Phase: Phase 2
SUMMARY

Prostate cancer is the most common cancer in Australian men. Robot-assisted radical prostatectomy (RARP) - surgical removal of the prostate - is a standard treatment, but it frequently causes erectile dysfunction (ED) and urinary incontinence that can persist for years and significantly affect quality of life. This trial (ROBOPREP) will test whether a multimodal program of prehabilitation (before surgery) and rehabilitation (after surgery) improves erectile function and urinary continence in men undergoing RARP, compared to standard care alone. The program includes four components, all delivered virtually and in a self-directed manner: 1. Pharmacological - tadalafil 5 mg once daily (a low-dose, TGA-approved erectile medication) beginning 4 weeks before surgery, paused during hospital admission, and resumed for 3 months following catheter removal after surgery. 2. Exercise - pelvic floor muscle training (3 sets per day) and aerobic exercise (40 minutes, 4 times per week) to strengthen the muscles and vascular supply involved in erectile and urinary function. 3. Nutrition - dietary guidance to support surgical recovery and vascular health. 4. Psychological/wellbeing - relaxation techniques, psychoeducation about expected recovery, and self-compassion strategies to address cancer-related anxiety. A total of 64 men will be recruited across three major Sydney hospitals (Royal Prince Alfred Hospital, Concord Repatriation General Hospital, and Chris O'Brien Lifehouse) and randomly assigned 1:1 to the multimodal program plus standard care, or to standard care alone. Outcomes - including erectile function (primary), urinary continence, quality of life, and psychological wellbeing - are assessed at baseline and at 6 weeks, 3, 6, and 12 months following surgery. All participant-facing elements of the program are digital, low-cost, and designed for real-world scalability.

Eligibility
Participation Requirements
Sex: Male
Minimum Age: 18
Healthy Volunteers: f
View:

• Adults aged ≥18 years undergoing elective robot-assisted radical prostatectomy (RARP) with curative intent for confirmed prostate cancer.

• Consulting a urological surgeon with an appointment at participating sites at least 4 weeks prior to scheduled surgery.

• Willingness to engage in prescribed self-directed interventions.

• Expected to have 100% unilateral OR \>50% bilateral nerve sparing at prostatectomy

Locations
Other Locations
Australia
Chris O'Brien Lifehouse
NOT_YET_RECRUITING
Sydney
Concord Repatriation General Hospital (CRGH)
RECRUITING
Sydney
Royal Prince Alfred Hospital
RECRUITING
Sydney
Contact Information
Primary
Nicholas Hirst
Nicholas.Hirst1@health.nsw.gov.au
+61 2 9515 3200
Backup
SOuRCe Admin
SLHD-SOuRCe@health.nsw.gov.au
Time Frame
Start Date: 2026-08-31
Estimated Completion Date: 2029-11-01
Participants
Target number of participants: 64
Treatments
Experimental: Multimodal Prehabilitation and Rehabilitation plus standard care
Participants receive standard care PLUS a multimodal program commencing ≥4 weeks preoperatively and continuing for 3 months postoperatively (following catheter removal). The program comprises four components: (1) tadalafil 5 mg orally once daily (paused during hospital admission); (2) pelvic floor muscle training 3 sets/day; (3) aerobic exercise 40 min, 4×/week; (4) nutritional guidance; and (5) psychological/wellbeing strategies. All non-pharmacological components are self-directed and digitally delivered.
Active_comparator: Standard Care
Participants receive usual high-standard perioperative care from their treating team, including clinical advice on exercise, nutrition, smoking cessation, alcohol reduction, expected surgical sequelae, and pelvic floor exercises, as well as medical considerations (blood sugar optimisation, medication review, anaemia screening). Prostate cancer nurse specialist consultations and urology clinic attendance are included as standard.
Sponsors
Leads: Surgical Outcomes Research Centre (SOuRCe)
Collaborators: Generic Health, National Health and Medical Research Council, Australia, Sydney Local Health District

This content was sourced from clinicaltrials.gov